RNU6-1012P

Across TCGA pan-cancer cohorts, RNU6-1012P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-1012P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1012P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1012P expression acts as an unfavorable survival marker.

KIRC, STAD, and KICH are the cancer types where RNU6-1012P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.369	0.883	<.001	144	view →
STAD	OS	Tertile	All	0.385	0.697	<.001	126	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
LIHC	OS	Tertile	All	0.130	0.707	<.001	54	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
UCEC	DFS	Tertile	All	0.768	0.898	.018	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-1012P–KIRC (OS)

Open the KIRC breakdown →